← All organizations
Highest phase reached
Phase 4
First clinical trial
Sep 1, 2004Last known activity
Jan 1, 2025
Timeline
1960s
- Jun 1, 1969
SK Chemicals— Founded
Drugs by trial phase (46 distinct, 61 trials)
Phase 4 (7 own, 0 via acquisition)
Phase 3 (20 own, 0 via acquisition)
Phase 2 (6 own, 0 via acquisition)
Phase 1 (7 own, 0 via acquisition)
Other trials (6 own, 0 via acquisition)
Indications
Studied for
- Acute Kidney Injury
- Alzheimer Disease
- Arterial Occlusive Diseases
- Asthma
- Carcinoma, Non-Small-Cell Lung
- Chickenpox
- Constipation
- Diabetes Mellitus
- Endometriosis
- Erectile Dysfunction
- Gastritis
- Gout
- Hepatitis B
- Herpes Zoster
- Hypertension
- Influenza, Human
- Irritable Bowel Syndrome
- Kidney Diseases
- Kidney Failure, Chronic
- Lung Neoplasms
- Migraine Disorders
- Peripheral Arterial Disease
- Peripheral Vascular Diseases
- Pneumococcal Infections
- Pruritus
- Renal Insufficiency
- Syndrome
- Typhoid Fever
- Urinary Bladder, Overactive
- Urologic Diseases
- Vestibular Neuronitis
Recent trials (50)
- NCT06989697CollaboratorPhase 3Jan 1, 2025
- NCT05445895Lead sponsorPhase 4Oct 31, 2022
- NCT05400395Lead sponsorPhase 4Sep 5, 2022
- NCT05453786Lead sponsorPhase 1Jun 23, 2022
- NCT05236998Lead sponsorPhase 1Nov 3, 2021
- NCT05906199Lead sponsorPhase 4Jul 28, 2021
- NCT04821687Lead sponsorPhase 4Jun 17, 2021
- NCT04718649CollaboratorN/AJan 31, 2021
- NCT05930080Lead sponsorPhase 3Jan 28, 2021
- NCT04401137Lead sponsorPhase 1Jul 1, 2020
- NCT03527355CollaboratorPhase 2Apr 18, 2018
- NCT03318276Lead sponsorPhase 3Feb 20, 2017
- NCT03020628Lead sponsorPhase 3Oct 1, 2016
- NCT03114943Lead sponsorPhase 3Jul 1, 2016
- NCT03114982Lead sponsorPhase 2May 1, 2016
Details
- Founded
- Seongnam, KR Jun 1, 1969
- Last known activity
- Jan 1, 2025